We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.


Download Mobile App
Recent News ECR 2021 Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Lung Ultrasound Bests X-Rays for COVID-19 Diagnosis

By MedImaging International staff writers
Posted on 16 Nov 2020
Lung ultrasound (LUS) is more reliable than an anterior-posterior chest x-ray (CXR) for detecting COVID-19, according to a new study.

Researchers at Temple University Hospital (Philadelphia, PA, USA) conducted a prospective study over a two-week period in April 2020, during which a surge in COVID-19 cases was observed. In all, 143 adult patients with signs and symptoms of COVID-19 were enrolled as they came into the emergency department (ED). The symptoms included a temperature of 38° Celsius or higher, a heart rate of 100 bpm or higher, a respiratory rate of 16 rpm or greater, oxygen saturation (SpO2) less than 94%, and a combination of cough, dyspnea, myalgia, malaise, ageusia, and anosmia.

Image: Lung ultrasound offers a better diagnostic option for COVID-19 (Photo courtesy of Getty Images)
Image: Lung ultrasound offers a better diagnostic option for COVID-19 (Photo courtesy of Getty Images)

The researchers compared the diagnostic performance of LUS performed with a portable hand-held device to CXR. For a definitive diagnosis, COVID-19 infection was confirmed with non-contrast-enhanced computed tomography (NCCT), a radiographic diagnostic standard that delivers near-perfect sensitivity of atypical pneumonia. The results revealed that in the 70 patients with both positive LUS and CXR test results, 58 had a positive NCCT. In the 42 patients with a positive LUS and a negative CXR, only 23 had a positive NCCT.

In the six patients who had a positive CXR and a negative LUS, there were no positive NCCTs, indicating lung ultrasound was the more reliable indicator. In all, they found that LUS had a sensitivity of 97.6% compared with CXR at 69.9%. Specificity was 33.3% for LUS and 44.4% for CXR. A total of 81 patients tested positive for COVID-19 with NCCT, for a disease prevalence of 75%. The study was presented at the American College of Emergency Physicians (ACEP), held online during October 2020.

“We continue to be confronted with a diagnostic challenge; patients often have vague non-specific multi-system presentations,” said lead author and study presenter Kendra Mendez, MD. “We found that lung ultrasound sensitivity outperforms chest x-ray for diagnosis of COVID-19 pneumonia. Lung ultrasound can be an especially valuable triage screening modality in resource-limited settings.”

While NCCT has excellent ability to detect COVID-19, the modality can't be used at patients' bedsides and it puts additional medical staff at risk for virus exposure. As a result, doctors all over the world are turning to lung ultrasound as an alternative imaging modality.

Related Links:
Temple University Hospital

Latest Ultrasound News